Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastasesLe-Chi Ye, Tian-Shu Liu, Li Ren, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 15, 2018
The role of oxaliplatin in the adjuvant setting of different Lauren's type of gastric adenocarcinoma after D2 gastrectomy: a real-world studyXi Cheng, Shan Yu, Yan Wang, et al.
Journal of Affective Disorders|April 26, 2026
Associations of loneliness and social isolation with the risk of suicide attempts: Insights from an observational and genetic analysisWei Hu, Tian-Shu Liu, Ge Tian, et al.
Neurology|May 14, 2026
Associations and Potential Biological Pathways Between Physical Frailty and Epilepsy Incidence: A Large-Scale Prospective Cohort StudyWei Hu, Tian-Shu Liu, Ge Tian, et al.
Oncotarget|September 8, 2016
Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX)Yan Wang, Rong-Yuan Zhuang, Yi-Yi Yu, et al.
Materials (Basel, Switzerland)|July 15, 2026
Research Progress on Microstructure Control and Strengthening Mechanisms of Aluminum Alloys for New Energy VehiclesJia-Shuai Chu, Hong-Yu Yang, Bai-Xin Dong, et al.
Plos Medicine|April 6, 2026
Physical frailty, genetic risk, mediating biomarkers, and risk of suicide attempt: A prospective cohort studyWei Hu, Li-Jie Gao, Tian-Shu Liu, et al.
Materials (Basel, Switzerland)|September 13, 2025
The Microstructure Regulation Mechanism and Future Application of Aluminum Alloys Manipulated by Nanocrystalline Structures Formed by In Situ Amorphous CrystallizationWen-Bo Yang, Lei Zhan, Lin Liu, et al.
British Journal of Cancer|June 23, 2026
Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trialJiajia Yuan, Jifang Gong, Zhi Peng, et al.
Journal of Translational Medicine|June 20, 2019
Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patientsGui-Qi Zhu, Yi Yang, Er-Bao Chen, et al.
Pageof 7